Quantcast

Latest National Cancer Institute Stories

Transformative Science
2014-09-10 03:22:07

A new public-private partnership is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.

2014-09-03 16:29:18

In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S.

2014-08-18 23:02:59

The anti-cancer drug Xalkori® is being investigated by the ECOG-ACRIN Cancer Research Group in E4512, a phase III trial. Philadelphia, PA (PRWEB) August

2014-08-01 23:07:36

The Mesothelioma Victims Center is releasing new information this week on where to find the most current and up-to-date news on treatment options from organizations such as the National Cancer

2014-07-28 23:01:12

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in

2014-07-08 08:29:42

CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related